Today's Top Gainer
Note:Top Gainer - Nifty 50 More
|Independent Director||Shirish Shetye|
|Independent Director||Lalit Jain|
|Company Secretary||Shweta Motwani|
Incorporated as a private limited company in Maharashtra in May 87, Bacil Pharma (BPL) was converted into a public limited company in Oct.90. BPL came out with a public issue of Rs 7 cr in Mar.94 to set up a plant at Vapi to manufacture bulk drugs like atenalol, norfloxacin, pefloxacin and ciprofloxacin. The comapany entered into a marketing arrangement with a distributor Kam Han Industries, Hong Kong, to export 50% of the production. Due to various reasons, the civil works at Vapi were affected. However, to avoid further delay in project implementation, the company acquired from SICOM an existing bulk drug unit with necessary infrastructure and production facilities at Lote Parashuram (near Ratnagiri).